FBDIX vs. SHRAX
Compare and contrast key facts about Franklin Biotechnology Discovery Fund (FBDIX) and ClearBridge Aggressive Growth Fund (SHRAX).
FBDIX is managed by Franklin Templeton. It was launched on Sep 14, 1997. SHRAX is managed by Franklin Templeton. It was launched on Oct 24, 1983.
Performance
FBDIX vs. SHRAX - Performance Comparison
Loading graphics...
FBDIX vs. SHRAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBDIX Franklin Biotechnology Discovery Fund | 2.34% | 52.68% | 15.37% | 18.40% | -12.65% | -27.58% | 29.85% | 49.11% | -15.77% | 18.83% |
SHRAX ClearBridge Aggressive Growth Fund | -7.17% | 13.50% | 12.02% | 24.09% | -25.43% | 7.35% | 19.74% | 24.26% | -7.93% | 14.22% |
Returns By Period
In the year-to-date period, FBDIX achieves a 2.34% return, which is significantly higher than SHRAX's -7.17% return. Over the past 10 years, FBDIX has outperformed SHRAX with an annualized return of 10.84%, while SHRAX has yielded a comparatively lower 7.12% annualized return.
FBDIX
- 1D
- 5.83%
- 1M
- -0.40%
- YTD
- 2.34%
- 6M
- 25.15%
- 1Y
- 69.79%
- 3Y*
- 28.39%
- 5Y*
- 7.17%
- 10Y*
- 10.84%
SHRAX
- 1D
- 3.40%
- 1M
- -6.68%
- YTD
- -7.17%
- 6M
- -8.75%
- 1Y
- 13.06%
- 3Y*
- 10.93%
- 5Y*
- 1.80%
- 10Y*
- 7.12%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBDIX vs. SHRAX - Expense Ratio Comparison
FBDIX has a 1.06% expense ratio, which is lower than SHRAX's 1.11% expense ratio.
Return for Risk
FBDIX vs. SHRAX — Risk / Return Rank
FBDIX
SHRAX
FBDIX vs. SHRAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Biotechnology Discovery Fund (FBDIX) and ClearBridge Aggressive Growth Fund (SHRAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBDIX | SHRAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.47 | 0.62 | +1.86 |
Sortino ratioReturn per unit of downside risk | 3.14 | 1.04 | +2.10 |
Omega ratioGain probability vs. loss probability | 1.40 | 1.14 | +0.26 |
Calmar ratioReturn relative to maximum drawdown | 4.35 | 0.96 | +3.39 |
Martin ratioReturn relative to average drawdown | 17.17 | 3.02 | +14.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBDIX | SHRAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.47 | 0.62 | +1.86 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.09 | +0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.34 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.45 | -0.04 |
Correlation
The correlation between FBDIX and SHRAX is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBDIX vs. SHRAX - Dividend Comparison
FBDIX's dividend yield for the trailing twelve months is around 10.56%, less than SHRAX's 23.99% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBDIX Franklin Biotechnology Discovery Fund | 10.56% | 10.81% | 19.53% | 0.00% | 0.13% | 0.98% | 14.50% | 18.77% | 3.72% | 2.39% | 4.57% | 8.42% |
SHRAX ClearBridge Aggressive Growth Fund | 23.99% | 22.27% | 20.39% | 13.77% | 15.63% | 26.11% | 18.42% | 12.71% | 18.97% | 5.97% | 4.76% | 4.03% |
Drawdowns
FBDIX vs. SHRAX - Drawdown Comparison
The maximum FBDIX drawdown since its inception was -71.44%, which is greater than SHRAX's maximum drawdown of -57.26%. Use the drawdown chart below to compare losses from any high point for FBDIX and SHRAX.
Loading graphics...
Drawdown Indicators
| FBDIX | SHRAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.44% | -57.26% | -14.18% |
Max Drawdown (1Y)Largest decline over 1 year | -12.39% | -14.59% | +2.20% |
Max Drawdown (5Y)Largest decline over 5 years | -46.83% | -33.77% | -13.06% |
Max Drawdown (10Y)Largest decline over 10 years | -53.67% | -33.77% | -19.90% |
Current DrawdownCurrent decline from peak | -1.98% | -11.69% | +9.71% |
Average DrawdownAverage peak-to-trough decline | -28.90% | -11.29% | -17.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.44% | 4.62% | -1.18% |
Volatility
FBDIX vs. SHRAX - Volatility Comparison
Franklin Biotechnology Discovery Fund (FBDIX) has a higher volatility of 9.67% compared to ClearBridge Aggressive Growth Fund (SHRAX) at 7.07%. This indicates that FBDIX's price experiences larger fluctuations and is considered to be riskier than SHRAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBDIX | SHRAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.67% | 7.07% | +2.60% |
Volatility (6M)Calculated over the trailing 6-month period | 16.55% | 13.63% | +2.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.07% | 23.09% | +2.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.57% | 20.84% | +4.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.40% | 20.85% | +5.55% |